SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (131)10/19/1999 11:53:00 AM
From: biowa  Read Replies (2) | Respond to of 438
 
Rick,

Sure you saw this, any thoughts?

biowa

----------------

Therion Biologics and National Cancer
Institute Initiate Phase II Trial of Novel
Melanoma Vaccines -- Newest vaccines join
Therion's cancer portfolio with additional <>

CAMBRIDGE, Mass., Oct. 18 /PRNewswire/

...Therion's tyrosinase vaccines will be tested alone and in conjunction with interleukin-2 (IL-2), a known immunostimulatory molecule, to evaluate IL-2's potential to enhance the immune response. The study is expected to enroll up to 73 patients...

...Steven A. Rosenberg, M.D., Chief of the NCI Surgery Branch, will serve as associate investigator...